Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas

Comparative Autoantibody and Immunologic Cell Marker Study

Concurrent Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Ixazomib and Dexamethasone Versus Ixazomib, Dexamethasone and Lenalidomide, Randomized With NFKB2 Rearrangement

A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer

Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)

Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

MRSI to Predict Response to RT/TMZ ± Belinostat in GBM

Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors

Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product

Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease

A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma

Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors

A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

CBCT for Spiritual Health Clinicians

Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer

Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses

Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma

Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation

A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer

Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer

Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma

Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma

Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer

A Survivorship Care Plan and Embedded Navigation Tool

Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation

A Study to Evaluate the Effect of Vitamin D on PFS in Indolent Non-Hodgkin's Lymphoma

Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma

Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy

PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy

Study of INCB053914 in Subjects With Advanced Malignancies

Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission

Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma

Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies

More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery